The U.S. Centers for Disease Control announced Swine flu vaccinations may be available 3 weeks earlier after health officials found single shot dose effective.
Georgia health law alert-Centers for Disease Control announces possible early Swine flu vaccine to combat flu outbreaks.
Atlanta, GA–Health officials with the U.S. Centers for Disease Control and Prevention (CDC) http://www.cdc.gov state Swine flu shots may start as early as three weeks. Swine flu outbreaks have ripped across the country since the start of the school year and CDC officials discovered a one shot flu vaccination shot, as opposed to the scheduled two shot immunization series, was effective within 8-10 days after administration. The previous Swine flu vaccination initiative was scheduled to begin in mid-October with a two shot immunization given to patients three weeks apart.
Washington State University announced over 2,500 cases of Swine flu and the CDC confirmed the incidence of the flu was higher this fall than in the last three years. Federal health officials are excited about possibly having a vaccine earlier and more effective for people. As reported by Bloomberg on September 13, 2009, U.S. Health officials along with healthcare leaders in the U.K thought two shots ere needed because people were exposed to the new virus for the first time. The recent positive results of the effectiveness of the one shot series brings good news to health officials who claimed the two dose vaccination series would not be available soon enough to quell the already widespread outbreaks of the flu since the start of the school year.
Numerous pharmaceutical manufacturers throughout the world are working tirelessly to produce the vaccine like Sanofi Aventis SA, GlaxoSmithKline Plc, and Novartis AG. The early supply of the vaccine will only be available to those most susceptible to the flu like pregnant women, children, and health care workers. Reports do not indicate any serious side effects after administration of the H1N1 Swine flu vaccine and shots are continued to be studied and monitored for safety and effectiveness. The current Swine flu vaccine trials are too small to reveal the development of rare conditions after administration.
Legal news reporter Heather L. Ryan for Georgia health and law education.